EMG-guided Neuro-Intermuscular Coordination Enhancement (NICE) Rehabilitation Through Human-Machine Interaction (NICE)

April 8, 2026 updated by: Jinsook Roh, University of Houston

Neuro-Intermuscular Coordination Enhancement (NICE) Rehabilitation

The objective of this study is to develop Neuro-Intermuscular Coordination Enhancement (NICE) rehabilitation, a novel neuromuscular control signal-guided strategy that visually guides stroke patients to individually activate groups of synergistic muscles through human-machine interaction. Ultimately, the development will lead to better clinical motor recovery, better quality of life, and lowered healthcare costs associated with the impairment.

Study Overview

Detailed Description

Stroke is the leading cause of severe long-term disability, affecting 9.4 million Americans. Each year around 800,000 people suffer a stroke even in the USA. Chronic upper extremity motor impairment is a major contributing factor to disability; functional use of the affected UE in daily life is a key factor for increased independence, return to work, and overall quality of life. Thus, effective and innovative treatment to address long-term disability is both a major public health need and an economic necessity.

The study will develop an innovative human-machine interaction platform to target and improve inter-joint coordination and motor function by enhancing muscular coordination in the UE. This study, in total, 38 chronic stroke survivors will be randomly assigned into two rehabilitation strategies either neuromuscular-coordination guided exercise (NICE; therapy group) or force-guided exercise (control group). The inclusion criteria primarily consist of: (1) having experienced an ischemic or hemorrhagic stroke at least 6 months prior (chronic stroke); (2) being between 21 and 80 years of age; (3) not having received botulinum toxin treatment in the affected arm within the past 3 months; and (4) having no cognitive impairments that would affect task comprehension or the ability to provide informed consent.

This study will evaluate the effects of both rehabilitation exercises on muscle coordination, standardized clinical scores, kinetics, and electroencephalogram.

Study Type

Interventional

Enrollment (Estimated)

48

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Texas
      • Houston, Texas, United States, 77045
        • Recruiting
        • University of Houston
        • Contact:
        • Principal Investigator:
          • Jinsook Roh, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Ischemic or hemorrhagic stroke
  • Aged between 21 and 80 years
  • Not receiving botulinum toxin on the impaired arm within 3 months
  • MAS ≤ 3 around elbow and shoulder

Exclusion Criteria:

  • have an orthopedic disorder involving upper limbs;
  • cognitive impairment sufficient to interfere with informed consent or successful completion of the protocol (Montreal Cognitive Assessment (MoCA) score =< 26);
  • a history of another neurologic disease;
  • anesthesia of joint position sense in upper limbs;
  • are pregnant or have a chance that they might be (self-reported);

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Neuromuscular coordination-guided rehabilitative training
Post-stroke participants will perform a center-out task by generating isometric contractions of multiple muscles to move the cursor on a screen while electromyographic (EMG) responses are recorded. Activation of each muscle (or muscle group) will be mapped to 1 of 4 directions within the multi-dimensional cursor space. We will derive the cursor position in real time using EMGs recorded from multiple arm muscles.
During training exercise, post-stroke participants will be asked to match the targets on the screen. The experimental group will match them by activating a specific set of muscle. During assessment trials, a physical therapist or occupational therapist will rate the functional level of arm impairment using FMA and ARAT.
Active Comparator: Force strengthening-guided rehabilitative training
Post-stroke participants will perform a center-out task by generating isometric force to move the cursor on a screen. Participants will generate isometric force, which will move their cursor on the monitor. They will be trained to match one of the four force targets on display. We will derive the cursor position in real time using three forces (Fx, Fy, and Fz) measured at the load cell.
During training exercise, post-stroke participants will be asked to match the targets on the screen. The active comparator group will match them by generating isometric force in a desired target direction. During assessment trials, a physical therapist or occupational therapist will rate the functional level of arm impairment using FMA and ARAT.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Fugl-Meyer Assessment (FMA) score
Time Frame: Pre-Training (baseline), post-training (6-week follow-up), 10-week and 18-week follow ups
To measure severity of motor impairment after stroke, FMA will be performed in the human upper extremity. FMA is commonly used to assess severity of motor impairment and motor recovery. The maximum FMA upper extremity motor score is 66 (i.e., 0: complete motor impairment; 66: normal motor performance). Each item is scored on a 3-point scale (0 = cannot perform, 1 = performs partially, 2 = performs fully).
Pre-Training (baseline), post-training (6-week follow-up), 10-week and 18-week follow ups
Change in similarity score of intermuscular coordination patterns
Time Frame: Pre-Training (baseline), post-training (6-week follow-up), 10-week and 18-week follow ups
EMGs will be recorded from 8 muscles. To assess whether muscle-synergy guided and/or force-guided exercise induce changes in the composition of intermuscular coordination patterns (ICoPs), non-negative matrix factorization will be applied to EMGs to identify and compare ICoPs.
Pre-Training (baseline), post-training (6-week follow-up), 10-week and 18-week follow ups

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in kinematic synergy
Time Frame: Pre-Training (baseline), post-training (6-week follow-up)
Kinematic synergies are a representation of multi-joint coordination. It will be identified using NNMF applied to the joint kinematic data obtained from 3D dynamic point-to-point reaching and drinking tasks.
Pre-Training (baseline), post-training (6-week follow-up)
Change in pairwise joint angle-to-angle correlation
Time Frame: Pre-Training (baseline), post-training (6-week follow-up)
Pairwise joint angle-to-angle correlation is a way to see the joint coupling using kinematic data. It will be calculated using Pearson's correlation coefficient between joint angles during the point-to-point reaching task.
Pre-Training (baseline), post-training (6-week follow-up)
Change in similarity score of intermuscular coordination patterns in dynamic task
Time Frame: Pre-Training (baseline), post-training (6-week follow-up)
Surface EMGs will be recorded from 8 key arm muscles during a 3D dynamic task and drinking task. Non-negative matrix factorization will be applied to EMGs to identify and compare intermuscular coordination patterns.
Pre-Training (baseline), post-training (6-week follow-up)
Change in active range of motion
Time Frame: Pre-Training (baseline), post-training (6-week follow-up)
The active range of motion will be calculated from full active range tasks for shoulder flexion/extension, internal/external rotation, abduction/adduction, elbow flexion/extension, and wrist pronation/supination.
Pre-Training (baseline), post-training (6-week follow-up)
Changes in EEG-derived spectral powers
Time Frame: Pre-Training (baseline), post-training (6-week follow-up)
EEG-derived spectral powers will be calculated, in resting and task conditions, across different frequency bands and different event-related spectral potentials across four different directions of target match.
Pre-Training (baseline), post-training (6-week follow-up)
Change in Revised Brain Symmetry Index
Time Frame: Pre-Training (baseline), post-training (6-week follow-up)
The revised brain symmetry index with EEG signals will be computed in the resting state during eyes open and closed conditions.
Pre-Training (baseline), post-training (6-week follow-up)
Change in cortico-muscular connectivity
Time Frame: Pre-Training (baseline), post-training (6-week follow-up)
Functional connectivity using a directed transfer function will be computed to identify the information flow and coherence among EEG and EMG signals in the desired brain region and muscle activation associated with directional (SE, SF, EE, EF) force generation.
Pre-Training (baseline), post-training (6-week follow-up)
Change in cortico-cortical connectivity
Time Frame: Pre-Training (baseline), post-training (6-week follow-up)
Functional connectivity using a directed transfer function will be computed to identify the information flow and coherenceamong EEG signals from different regions of interest (sources, e.g., ipsi and contralesional fronto-parietal regions, primary motor cortex and somatosensory cortices).
Pre-Training (baseline), post-training (6-week follow-up)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Action Research Arm Test (ARAT) score
Time Frame: Pre-Training (baseline), post-training (6-week follow-up)
To measure motor function after stroke, ARAT will be performed in the human upper extremity. 19 Items comprising the ARAT are categorized into four subscales (grasp, grip, pinch, and gross movement) and arranged in order of decreasing difficulty, with the most difficult task examined first, followed by the least difficult task. Task performance is rated on a 4-point scale, ranging from 0 (no movement) to 3 (movement performed normally).
Pre-Training (baseline), post-training (6-week follow-up)
Change in Modified Ashworth Scale (MAS)
Time Frame: Pre-Training (baseline), post-training (6-week follow-up)
The increase in muscle tone will be assessed through MAS around the elbow and shoulder. MAS score ranges from 0 to 5.
Pre-Training (baseline), post-training (6-week follow-up)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jinsook Roh, PhD, University of Houston

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 10, 2023

Primary Completion (Estimated)

August 1, 2029

Study Completion (Estimated)

August 1, 2030

Study Registration Dates

First Submitted

October 22, 2025

First Submitted That Met QC Criteria

April 8, 2026

First Posted (Actual)

April 15, 2026

Study Record Updates

Last Update Posted (Actual)

April 15, 2026

Last Update Submitted That Met QC Criteria

April 8, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Neuromuscular coordination-guided rehabilitative training

Subscribe